Stay updated with breaking news from Dean For Research Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-Total Revenues of $2.0 Billion in 2022, Including 23 Percent Annual Increase in Total Net Product Sales to $1.7 Billion--TUKYSA Granted FDA Accelerated Approval for Previously Treated RAS Wild-Type, HER2-Positive Metastatic Colorectal Cancer--ADCETRIS Received Pediatric Indication with FDA Approval for Children wit...
GuruFocus Article or News written by ACCESSWIRE and the topic is about:
SAN FRANCISCO, CA / ACCESSWIRE / January 11, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) and its wholly owned subsidiary Napo Pharmaceuticals (Napo) today announced that Sandra M. Swain, MD, FACP, FASCO has
Escobar’s appointment takes effect July 1, 2022.
Results of the study provide the first proof-of-concept data for potential use of crofelemer - a novel, oral, plant-based, non-opioid antidiarrheal prescription medication - in breast cancer patientsSAN